NCI Failed to Publish Two Bypass Budgets As Funds Tightened and Sequestration Set In
Guest Editorial: Andrew Vickers on PSA Skepticism, Rational and Irrational
UT Board Announces Support for MD Anderson Tenure System
Study: Drug Discounts Used For Wealthier Patients In Many 340B-Enrolled Hospitals
In Brief: ESMO Names Annual Award Winners
Drugs and Targets: Akynzeo approved for chemotherapy-related nausea
Trending Stories
- She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research
- First-ever financial toxicity tumor board aims to change the standard of care
Researchers focus on debt as a side effect of cancer, treatment amid cuts to Medicaid, NCI - HHS seems poised to exert control over USPSTF
Ransohoff: The task force is the pinnacle of evidence-based medicine - An overlooked immune cell population may offer new direction for cell and gene therapy
- Understanding the impact of the Israeli-U.S. attacks on Iran’s nuclear facilities
- Rick and Mary Pazdur on facing “the other side of the stethoscope”
A few months before Mary died of ovarian cancer, the couple shared how this experience shaped their perspectives on oncology